Exagen Inc. Revenue 2018–2025
Exagen Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Exagen Inc. revenue for the quarter ending March 31, 2026 was 17.3 M, a 11.67% increase year-over-year.
- Exagen Inc. revenue for the twelve months ending March 31, 2026 was 67.3 M, a 21.39% increase year-over-year.
- Exagen Inc. annual revenue for 2025 was 66.6 M, a 19.65% increase from 2024.
- Exagen Inc. annual revenue for 2024 was 55.6 M, a 5.89% increase from 2023.
- Exagen Inc. annual revenue for 2023 was 52.5 M, a 15.33% increase from 2022.
- Exagen Inc. annual revenue for 2022 was 45.6 M.
Exagen Inc. (XGN) — Frequently Asked Questions
Exagen Inc. (XGN) is a publicly traded US company. It has a market capitalization of $90M. In fiscal 2025 it reported revenue of $67M and net income of -$20M. Explore XGN's stock price, financial statements, earnings history, margins and key ratios below.
What is Exagen Inc.'s market cap?
Exagen Inc. (XGN) has a market capitalization of $90M.
What is the XGN stock price?
XGN trades at $4.19 (-2.78% on the day).
How much revenue does Exagen Inc. make?
Exagen Inc. reported revenue of $67M in fiscal 2025.
Is XGN profitable?
In fiscal 2025, Exagen Inc. reported net income of -$20M.